{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:08:55Z","timestamp":1771034935801,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772542"],"award-info":[{"award-number":["81772542"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072648"],"award-info":[{"award-number":["82072648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273011"],"award-info":[{"award-number":["82273011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20211508"],"award-info":[{"award-number":["BK20211508"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["JQX21009"],"award-info":[{"award-number":["JQX21009"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["021414380500"],"award-info":[{"award-number":["021414380500"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.intimp.2022.109384","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T01:29:00Z","timestamp":1667525340000},"page":"109384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"PA","title":["Dectin3 protects against hepatocellular carcinoma by regulating glycolysis of macrophages"],"prefix":"10.1016","volume":"113","author":[{"given":"Wei","family":"Qu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuping","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingming","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109384_b0005","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic Landscape and Biomarkers of Hepatocellular Carcinoma","volume":"149","author":"Zucman-Rossi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2022.109384_b0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","article-title":"Advances in molecular classification and precision oncology in hepatocellular carcinoma","volume":"72","author":"Rebouissou","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2022.109384_b0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/hep.30801","article-title":"Tumor Necrosis Factor Receptor-Associated Factor 6 Promotes Hepatocarcinogenesis by Interacting With Histone Deacetylase 3 to Enhance c-Myc Gene Expression and Protein Stability","volume":"71","author":"Wu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2022.109384_b0020","article-title":"Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study","author":"Buch","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2022.109384_b0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9997","key":"10.1016\/j.intimp.2022.109384_b0030","article-title":"Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept","volume":"8","author":"De Lorenzo","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.intimp.2022.109384_b0035","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/17474124.2021.1973431","article-title":"First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges","volume":"15","author":"Rizzo","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.intimp.2022.109384_b0040","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.intimp.2022.109384_b0045","doi-asserted-by":"crossref","unstructured":"Benson, A. B., D'Angelica, M. I., Abbott, D. E., Anaya, D. A., Anders, R., Are, C., Bachini, M., Borad, M., Brown, D., Burgoyne, A., Chahal, P., Chang, D. T., Cloyd, J., Covey, A. M., Glazer, E. S., Goyal, L., Hawkins, W. G., Iyer, R., Jacob, R., Kelley, R. K., Kim, R., Levine, M., Palta, M., Park, J. O., Raman, S., Reddy, S., Sahai, V., Schefter, T., Singh, G., Stein, S., Vauthey, J. N., Venook, A. P., Yopp, A., McMillian, N. R., Hochstetler, C., and Darlow, S. D. 2021. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19:541.","DOI":"10.6004\/jnccn.2021.0022"},{"key":"10.1016\/j.intimp.2022.109384_b0050","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1470-2045(21)00151-0","article-title":"Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial","volume":"22","author":"Galle","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.intimp.2022.109384_b0055","doi-asserted-by":"crossref","unstructured":"Rizzo, A., Nannini, M., Novelli, M., Dalia Ricci, A., Scioscio, V. D., and Pantaleo, M. A. 2020. Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis. Ther Adv Med Oncol 12:1758835920936932.","DOI":"10.1177\/1758835920936932"},{"key":"10.1016\/j.intimp.2022.109384_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082096","article-title":"The State of Immunotherapy in Hepatobiliary Cancers","volume":"10","author":"Ilyas","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2022.109384_b0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/17474124.2022.2064273","article-title":"Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?","volume":"16","author":"Rizzo","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.intimp.2022.109384_b0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.intimp.2022.109384_b0075","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2022.109384_b0080","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3892\/or.2014.3587","article-title":"Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7\u2013H3 expression","volume":"33","author":"Kang","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1016\/j.intimp.2022.109384_b0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2022.109384_b0090","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cmet.2011.11.013","article-title":"Orchestration of metabolism by macrophages","volume":"15","author":"Biswas","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.intimp.2022.109384_b0095","first-page":"420","article-title":"Metabolic reprograming in macrophage polarization","volume":"5","author":"Galv\u00e1n-Pe\u00f1a","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2022.109384_b0100","first-page":"e1600200","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Fundamentals of cancer metabolism. Sci Adv"},{"key":"10.1016\/j.intimp.2022.109384_b0105","doi-asserted-by":"crossref","first-page":"847","DOI":"10.14348\/molcells.2016.0310","article-title":"Cancer Metabolism: Fueling More than Just Growth","volume":"39","author":"Lee","year":"2016","journal-title":"Mol Cells"},{"key":"10.1016\/j.intimp.2022.109384_b0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.intimp.2022.109384_b0115","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fimmu.2015.00408","article-title":"Targeting C-Type Lectin Receptors for Cancer Immunity","volume":"6","author":"Yan","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2022.109384_b0120","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.celrep.2015.10.058","article-title":"Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways","volume":"13","author":"Seifert","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.intimp.2022.109384_b0125","doi-asserted-by":"crossref","first-page":"14097","DOI":"10.1073\/pnas.1617903113","article-title":"The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis","volume":"113","author":"Kimura","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2022.109384_b0130","doi-asserted-by":"crossref","first-page":"25964","DOI":"10.1074\/jbc.M112.384164","article-title":"The C-type lectin receptor CLECSF8 (CLEC4D) is expressed by myeloid cells and triggers cellular activation through Syk kinase","volume":"287","author":"Graham","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2022.109384_b0135","doi-asserted-by":"crossref","unstructured":"LeibundGut-Landmann, S., Gross, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., and Reis e Sousa, C. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8:630.","DOI":"10.1038\/ni1460"},{"key":"10.1016\/j.intimp.2022.109384_b0140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/1573406413666170510103030","article-title":"C-type Lectin Receptor: Old Friend and New Player","volume":"13","author":"Hou","year":"2017","journal-title":"Med Chem"},{"key":"10.1016\/j.intimp.2022.109384_b0145","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1111\/j.1742-4658.2005.05031.x","article-title":"The C-type lectin-like domain superfamily","volume":"272","author":"Zelensky","year":"2005","journal-title":"Febs j"},{"key":"10.1016\/j.intimp.2022.109384_b0150","doi-asserted-by":"crossref","first-page":"e105320","DOI":"10.15252\/embj.2020105320","article-title":"Fungal-induced glycolysis in macrophages promotes colon cancer by enhancing innate lymphoid cell secretion of IL-22","volume":"40","author":"Zhu","year":"2021","journal-title":"Embo j"},{"key":"10.1016\/j.intimp.2022.109384_b0155","article-title":"CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.intimp.2022.109384_b0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fimmu.2018.00227","article-title":"C-Type Lectin-Like Receptors As Emerging Orchestrators of Sterile Inflammation Represent Potential Therapeutic Targets","volume":"9","author":"Chiffoleau","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2022.109384_b0165","doi-asserted-by":"crossref","first-page":"e1005662","DOI":"10.1371\/journal.ppat.1005662","article-title":"Dectin-3 Deficiency Promotes Colitis Development due to Impaired Antifungal Innate Immune Responses in the Gut","volume":"12","author":"Wang","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.intimp.2022.109384_b0170","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cell.2014.11.018","article-title":"Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment","volume":"159","author":"Lavin","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2022.109384_b0175","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2022.109384_b0180","doi-asserted-by":"crossref","first-page":"e1000371","DOI":"10.1371\/journal.ppat.1000371","article-title":"Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis","volume":"5","author":"Pesce","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.intimp.2022.109384_b0185","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.immuni.2015.02.001","article-title":"Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1\u03b1","volume":"42","author":"Shalova","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2022.109384_b0190","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1021\/acs.jproteome.6b00604","article-title":"Comprehensive Proteomics Analysis Reveals Metabolic Reprogramming of Tumor-Associated Macrophages Stimulated by the Tumor Microenvironment","volume":"16","author":"Liu","year":"2017","journal-title":"J Proteome Res"},{"key":"10.1016\/j.intimp.2022.109384_b0195","doi-asserted-by":"crossref","unstructured":"Penny, H. L., Sieow, J. L., Adriani, G., Yeap, W. H., See Chi Ee, P., San Luis, B., Lee, B., Lee, T., Mak, S. Y., Ho, Y. S., Lam, K. P., Ong, C. K., Huang, R. Y., Ginhoux, F., Rotzschke, O., Kamm, R. D., and Wong, S. C. 2016. Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma. Oncoimmunology 5:e1191731.","DOI":"10.1080\/2162402X.2016.1191731"},{"key":"10.1016\/j.intimp.2022.109384_b0200","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.4049\/jimmunol.1600345","article-title":"Correction: Dectin-1 Activation by a Natural Product \u03b2-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype","volume":"196","author":"Liu","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2022.109384_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.783236","article-title":"Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma","volume":"12","author":"Xing","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2022.109384_b0210","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fonc.2018.00269","article-title":"Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma","volume":"8","author":"Shrestha","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.intimp.2022.109384_b0215","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20191519","article-title":"Association between dectin-1 gene single nucleotide polymorphisms and fungal infection: a systemic review and meta-analysis","volume":"39","author":"Zhou","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.intimp.2022.109384_b0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1200\/JCO.20.01892","article-title":"Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression","volume":"39","author":"Cheung","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.intimp.2022.109384_b0225","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.30811","article-title":"Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma","volume":"71","author":"Nault","year":"2020","journal-title":"Hepatology"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922008682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922008682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:02:34Z","timestamp":1761588154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922008682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":45,"alternative-id":["S1567576922008682"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109384","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dectin3 protects against hepatocellular carcinoma by regulating glycolysis of macrophages","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109384"}}